Enlivex Therapeutics Ltd.
Stock Forecast, Prediction & Price Target
Enlivex Therapeutics Ltd. Financial Estimates
Enlivex Therapeutics Ltd. Revenue Estimates
Enlivex Therapeutics Ltd. EBITDA Estimates
Enlivex Therapeutics Ltd. Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | |||
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $0 Low: $0 High: $0 avg. 0% | |||
Net Income
% change YoY
| $-9.64M N/A | $-42.40M -339.54% | $-29.06M 31.45% | Avg: $-10.95M Low: $-10.95M High: $-10.95M avg. 62.29% | |||
EBITDA
% change YoY
| $-23.77M N/A | $-18.93M 20.33% | $-28.21M -49.02% | Avg: $0 Low: $0 High: $0 avg. 100% | |||
EPS
% change YoY
| -$0.54 N/A | -$2.31 -327.77% | -$1.56 32.46% | Avg: -$0.59 Low: -$0.59 High: -$0.59 avg. 62.17% | |||
Operating Expenses
% change YoY
| $19.28M N/A | $25.79M 33.74% | $29.39M 13.94% | Avg: $0 Low: $0 High: $0 avg. -100% | |||
FAQ
What is Enlivex Therapeutics Ltd. stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 62.29% in 2025-2025.
We have gathered data from 1 analysts. Their low estimate is -10.95M, average is -10.95M and high is -10.95M.
What is Enlivex Therapeutics Ltd. stock revenue growth forecast?
We have gathered data from N/A analysts. Their low revenue estimate is N/A, average is N/A and high is N/A.
What is Enlivex Therapeutics Ltd. stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 62.17% in 2025-2025.
We have gathered data from 1 analysts. Their low earnings per share estimate is -$0.59, average is -$0.59 and high is $-0.59.